BIOCELL2025，Vol.49Issue(10)：P.1859-1871,13.DOI:10.32604/biocell.2025.068773
Emerging Roles of Fc Receptor-Like 1 in Immunotherapy of Diffuse Large B-Cell Lymphoma
Kayce Blumenstock 1Vandana Zaman 2Camille Green 3Narendra L.Banik 4Azizul Haque4
作者信息
- 1. Department of Pharmacology and Immunology,Medical University of South Carolina,173 Ashley Avenue,Charleston,SC 29425,USA Ralph H.Johnson Veterans Administration Medical Center,109 Bee St,Charleston,SC 29401,USA
- 2. Ralph H.Johnson Veterans Administration Medical Center,109 Bee St,Charleston,SC 29401,USA Department of Neurosurgery,Medical University of South Carolina,96 Jonathan Lucas Street,Charleston,SC 29425,USA
- 3. Department of Neurosurgery,Medical University of South Carolina,96 Jonathan Lucas Street,Charleston,SC 29425,USA
- 4. Department of Pharmacology and Immunology,Medical University of South Carolina,173 Ashley Avenue,Charleston,SC 29425,USA Ralph H.Johnson Veterans Administration Medical Center,109 Bee St,Charleston,SC 29401,USA Department of Neurosurgery,Medical University of South Carolina,96 Jonathan Lucas Street,Charleston,SC 29425,USA
- 折叠
摘要
关键词
Fc receptor-like 1(FCRL1)/non-Hodgkin’s lymphoma(NHL)/diffuse large B-cell lymphoma(DLBCL)/immunoreceptor tyrosine-based activation motif(ITAM)/immunoreceptor tyrosine-based inhibiting motif(ITIM)/immunotherapy分类
医药卫生引用本文复制引用
Kayce Blumenstock,Vandana Zaman,Camille Green,Narendra L.Banik,Azizul Haque..Emerging Roles of Fc Receptor-Like 1 in Immunotherapy of Diffuse Large B-Cell Lymphoma[J].BIOCELL,2025,49(10):P.1859-1871,13.基金项目
supported by funding from the Veterans Administration(I01 BX006101-01) （I01 BX006101-01）
supported in part by funding from the Veterans Administration(IO1 BX001262) （IO1 BX001262）
the recipient of RCS Award(IK6 BX005964)from the Department of Veterans Administration. （IK6 BX005964）
